Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Ridker PM et al. - Authors hypothesized that people with elevated high-sensitivity C-reactive protein levels but without hyperlipidemia might benefit from statin treatment. In this trial of apparently healthy persons without hyperlipidemia but with elevated high-sensitivity C-reactive protein levels, rosuvastatin significantly reduced the incidence of major cardiovascular events. [more...]
